| Authors: |
Velez MA; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA., Kang ES; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA., Thompson CA; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA., Lind-Lebuffe J; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA., Shen C; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA., Park SJ; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA., Han A; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA., Gower A; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA., Li D; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA., Rochigneux P; Department of Medical Oncology, Paoli-Calmettes Institute, Marseille, France., Grogan TR; UCLA Department of Medicine Statistics Core, University of California, Los Angeles, Los Angeles, CA., Elashoff DA; UCLA Department of Medicine Statistics Core, University of California, Los Angeles, Los Angeles, CA., Garon EB; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA., Lisberg A; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA. |
